Medical Journals

Insights into Drug Metabolism from Modelling Studies of Cytochrome P450-drug Interactions.

Authors:
  • MarĂ©chal Jean-Didier
  • Sutcliffe Michael J

From: Manchester Interdisciplinary Biocentre & School of Chemical Engineering and Analytical Science, University of Manchester, 131 Princess Street, Manchester, M1 7NDUK.

Current topics in medicinal chemistry

  • Publish Date: 2006
  • ISSN: 1568-0266
  • Volume: 6
  • Issue: 15
  • Pages: 1619-26
  • Medium: Print
  • Language: English
  • Citation (JAMA): MarĂ©chal Jean-Didier, Sutcliffe Michael J, et al. Insights into Drug Metabolism from Modelling Studies of Cytochrome P450-drug Interactions.. 2006;6:1619-26

Abstract

The cytochromes P450 (CYPs) comprise a vast superfamily of enzymes found in virtually all life forms. In mammals, xenobiotic metabolising CYPs provide crucial protection from the harmful effects of exposure to a wide variety of chemicals, including environmental toxins and therapeutic drugs. Elucidating the structural features of CYPs that contribute to their metabolism of structurally diverse substrates impacts on the rational design of improved therapeutic drugs and specific inhibitors. Models capable of predicting the possible involvement of CYPs in the metabolism of drugs or drug candidates are thus important tools in drug discovery and development. Ideally, functional information would be obtained from crystal structures of all the CYPs of interest. Initially only crystal structures of distantly related bacterial CYPs were available - comparative modelling techniques were used to bridge the gap and produce structural models of human CYPs, and thereby obtain some useful functional information. A significant step forward in the reliability of these models came six years ago with the first crystal structure of a mammalian CYP, rabbit CYP2C5, followed by the structures of five human enzymes, CYP2A6, CYP2C8, CYP2C9, CYP2D6 and CYP3A4, and a second rabbit enzyme, CYP2B4. The evolution of a CYP2D6 model, leading to the validation of the model as an in silico tool for predicting binding and metabolism, is presented as a case study.

Mesh Headings (Keywords): Animals, Binding Sites, Cytochrome P-450 Enzyme System, Drug Interactions, Humans, Models, Molecular


Check for Full Text / PubMed Unique Identifier (PMID): 16918473


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.